REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The overall objective of the study was to describe the long-term effectiveness and safety of
etanercept in patients with psoriatic arthritis in a Canadian clinical practice setting.